PMID- 38026878 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231201 IS - 2296-4185 (Print) IS - 2296-4185 (Electronic) IS - 2296-4185 (Linking) VI - 11 DP - 2023 TI - Biomimetic electrospun nanofibrous scaffold for tissue engineering: preparation, optimization by design of experiments (DOE), in-vitro and in-vivo characterization. PG - 1288539 LID - 10.3389/fbioe.2023.1288539 [doi] LID - 1288539 AB - Electrospinning is a versatile method for fabrication of precised nanofibrous materials for various biomedical application including tissue engineering and drug delivery. This research is aimed to fabricate the PVP/PVA nanofiber scaffold by novel electrospinning technique and to investigate the impact of process parameters (flow rate, voltage and distance) and polymer concentration/solvent combinations influence on properties of electrospun nanofibers. The in-vitro and in-vivo degradation studies were performed to evaluate the potential of electrospun PVP/PVA as a tissue engineering scaffold. The solvents used for electrospinning of PVP/PVA nanofibers were ethanol and 90% acetic acid, optimized with central composite design via Design Expert software. NF-2 and NF-35 were selected as optimised nanofiber formulation in acetic acid and ethanol, and their characterization showed diameter of 150-400 nm, tensile strength of 18.3 and 13.1 MPa, respectively. XRD data revealed the amorphous nature, and exhibited hydrophilicity (contact angles: 67.89 degrees and 58.31 degrees for NF-2 and NF-35). Swelling and in-vitro degradability studies displayed extended water retention as well as delayed degradation. FTIR analysis confirmed solvent-independent interactions. Additionally, hemolysis and in-vitro cytotoxicity studies revealed the non-toxic nature of fabricated scaffolds on RBCs and L929 fibroblast cells. Subcutaneous rat implantation assessed tissue response, month-long biodegradation, and biocompatibility through histological analysis of surrounding tissue. Due to its excellent biocompatibility, this porous PVP/PVA nanofiber has great potential for biomedical applications. CI - Copyright (c) 2023 Anjum, Li, Arya, Ali, Alarifi, Yulin, Hengtong, Rajinikanth and Ao. FAU - Anjum, Shabnam AU - Anjum S AD - Department of Tissue Engineering, School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, China. AD - NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, National Engineering Research Centre for Biomaterials, Institute of Regulatory Science for Medical Device, Sichuan University, Chengdu, Sichuan, China. FAU - Li, Ting AU - Li T AD - Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. FAU - Arya, Dilip Kumar AU - Arya DK AD - Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Lucknow, India. FAU - Ali, Daoud AU - Ali D AD - Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia. FAU - Alarifi, Saud AU - Alarifi S AD - Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia. FAU - Yulin, Wang AU - Yulin W AD - NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, National Engineering Research Centre for Biomaterials, Institute of Regulatory Science for Medical Device, Sichuan University, Chengdu, Sichuan, China. FAU - Hengtong, Zhang AU - Hengtong Z AD - NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, National Engineering Research Centre for Biomaterials, Institute of Regulatory Science for Medical Device, Sichuan University, Chengdu, Sichuan, China. FAU - Rajinikanth, P S AU - Rajinikanth PS AD - Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Lucknow, India. FAU - Ao, Qiang AU - Ao Q AD - Department of Tissue Engineering, School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, China. AD - NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, National Engineering Research Centre for Biomaterials, Institute of Regulatory Science for Medical Device, Sichuan University, Chengdu, Sichuan, China. LA - eng PT - Journal Article DEP - 20231031 PL - Switzerland TA - Front Bioeng Biotechnol JT - Frontiers in bioengineering and biotechnology JID - 101632513 PMC - PMC10646156 OTO - NOTNLM OT - PVA OT - PVP OT - electrospinning OT - subcutaneous implant OT - tissue engineering COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/11/29 18:41 MHDA- 2023/11/29 18:42 PMCR- 2023/01/01 CRDT- 2023/11/29 16:58 PHST- 2023/09/06 00:00 [received] PHST- 2023/10/16 00:00 [accepted] PHST- 2023/11/29 18:42 [medline] PHST- 2023/11/29 18:41 [pubmed] PHST- 2023/11/29 16:58 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 1288539 [pii] AID - 10.3389/fbioe.2023.1288539 [doi] PST - epublish SO - Front Bioeng Biotechnol. 2023 Oct 31;11:1288539. doi: 10.3389/fbioe.2023.1288539. eCollection 2023.